Koji Yamanoi

1.5k citations
72 papers · 946 indexed · 1 hit paper · h-index 12

Koji Yamanoi

55 papers receiving 941 citations

Hit Papers

Tumor Immune Microenvironment during Epithelial–Mesenchym...227202120262022202450100150200

Peers

Koji Yamanoi
Comparison fields: 5 of 82
  • Reproductive Medicine 164
  • Immunology 362
  • Oncology 464
  • Cancer Research 228
  • Obstetrics and Gynecology 93
Replace Tomoyuki Sasano with:
Tomoyuki Sasano Japan
Mark E. Borowsky United States
Natalie Y.L. Ngoi Singapore
Julian A. Gingold United States
Evelien W. Duiker Netherlands
Nana Tchabo United States
Matin Sheriff United Kingdom
Suha Deen United Kingdom
Francesca Milano Netherlands
Valentina Tuninetti Italy
Koji Yamanoi relative to Tomoyuki Sasano Japan Tomoyuki Sasano's profile →
Citations per field
00.5×
Tomoyuki Sasano · 1×
Citations per year

Countries citing papers authored by Koji Yamanoi

Since Specialization
Citations

This map shows the geographic impact of Koji Yamanoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Yamanoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Yamanoi more than expected).

Fields of papers citing papers by Koji Yamanoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Yamanoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Yamanoi. The network helps show where Koji Yamanoi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Koji Yamanoi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Koji Yamanoi Line = papers co-authored together Koji Yamanoi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20250
4 20251
5 20251
6 20244
7 20247
8 20245
9 20241
10 20241
11 20242
12 20231
13 20231
14 20224
15 202210
16 20221
17 20217
18 20211
19 20191
20 201315

About Koji Yamanoi

Koji Yamanoi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Oncology, having authored 72 papers that have together received 946 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (19 papers), Uterine Myomas and Treatments (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cervical Cancer and HPV Research (7 papers), Cancer Genomics and Diagnostics (6 papers), Endometriosis Research and Treatment (6 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Reproductive Medicine (164 citations), Immunology (362 citations) and Oncology (464 citations). Koji Yamanoi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masaki Mandai, Ken Yamaguchi, Junzo Hamanishi, Noriomi Matsumura, Tsukasa Baba, Kaoru Abiko, Ryusuke Murakami, Mana Taki, Masayo Ukita and Ikuo Konishi. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026